XML 30 R20.htm IDEA: XBRL DOCUMENT v3.23.3
Fair Value Measurements
9 Months Ended
Sep. 29, 2023
Fair Value Disclosures [Abstract]  
Fair Value Measurements Fair Value MeasurementsThe carrying values of financial instruments, including Trade receivables and Accounts payable, approximate their fair values due to their short-term maturities. The estimated fair values may not represent actual values of the financial instruments that could be realized as of the balance sheet date or that will be realized in the future.
A summary of the Company’s assets and liabilities that are measured at fair value for each fair value hierarchy level for the periods presented is as follows:
September 29, 2023
Level
One
Level
Two
Level
Three
Total
(In thousands)
Assets:
Cash equivalents$2,301 $— $— $2,301 
Foreign currency contracts - not designated as hedges— 612 — 612 
Interest rate swap agreements— 16,798 — 16,798 
Deferred compensation plans— 3,205 — 3,205 
$2,301 $20,615 $— $22,916 
Liabilities:
Foreign currency contracts - not designated as hedges$— $2,957 $— $2,957 
Cross currency swap agreements— 9,645 — 9,645 
Deferred compensation plans— 3,205 — 3,205 
$— $15,807 $— $15,807 

December 31, 2022
Level
One
Level
Two
Level
Three
Total
(In thousands)
Assets:
Cash equivalents$8,195 $— $— $8,195 
Foreign currency contracts - not designated as hedges— 3,682 — 3,682 
Interest rate swap agreements— 14,342 — 14,342 
Deferred compensation plans— 2,501 — 2,501 
$8,195 $20,525 $— $28,720 
Liabilities:
Foreign currency contracts - not designated as hedges$— $2,166 $— $2,166 
Cross currency swap agreements — 10,769 — 10,769 
Deferred compensation plans— 2,501 — 2,501 
$— $15,436 $— $15,436 

The Company measures the fair value of foreign currency contracts, cross currency swap agreements and interest rate swap agreements using Level Two inputs based on observable spot and forward rates in active markets. Additionally, the fair value of derivatives designated in hedging relationships includes a credit valuation adjustment to appropriately incorporate nonperformance risk for the Company and the respective counterparty. For the nine months ended September 29, 2023, the impact of the credit valuation adjustment on the Company’s derivatives is immaterial. Refer to Note 10 “Derivatives” for additional information.

There were no transfers in or out of Level One, Two or Three during the nine months ended September 29, 2023.